European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
The committee said Leqembi's effect on delaying cognitive decline does not outweigh "the risk of serious side effects associated with
Read More
Pharmaceuticals
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into
Read More
Novo Nordisk’s Wegovy wins EU backing for reducing heart risks
Novo Nordisk's Wegovy has received backing from the EU's medical regulator to expand the weight loss drug's use to reducing
Read More
After leaving Google, Jakob Uszkoreit started Inceptive to apply AI to drug development
Inceptive CEO Jakob Uszkoreit helped invent the tech behind generative AI. Now, he says it will change the pharmaceutical industry
Read More
Pfizer moves forward with once-daily version of weight loss pill after setbacks
The company plans to conduct studies in the second half of the year evaluating multiple doses of the drug. Source
Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye
Read More
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an
Read More
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
President Joe Biden has made lowering U.S. drug prices a key pillar of his health-care agenda and reelection platform for
Read More
Novo Nordisk’s Wegovy weight loss drug approved in China
Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management. Source
Read More